Nucleic Acid Therapeutics

Editorial Board

Co-Editors-in-Chief

Bruce A. Sullenger, PhD
Director, Duke Translational Research Institute
Joseph and Dorothy Beard Professor
Department of Surgery
Duke University Medical Center
Durham, NC  
bruce.sullenger@duke.edu

C.A. Stein, MD, PhD
Chair of Medical Oncology and Experimental Therapeutics
City of Hope National Medical Center
1500 E.  Duarte Road
Duarte, CA 91010
cstein@coh.org

Executive Editor

Fintan Steele, PhD
SomaLogic
Boulder, CO
fsteele@liebertpub.com

Consulting Editor

Graham C. Parker, PhD
gparker@liebertpub.com

Senior Editors

Mark A. Kay, MD, PhD
Dennis Farrey Family Professor
Departments of Pediatrics and Genetics
Vice Chair for Basic Research (Pediatrics)
Stanford University School of Medicine
Stanford, CA
markay@stanford.edu

Dieter C.  Gruenert, PhD
The Department of Otolaryngology-Head and Neck Surgery
Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research
University of California, San Francisco
San Francisco, CA 
dgruenert@ohns.ucsf.edu

European Editor

Jens Kurreck, PhD
Technische Universität Berlin
Institute of Biotechnology, TIB 4/3-2
Department of Applied Biochemistry
Berlin, Germany
jens.kurreck@tu-berlin.de 

Asian Editor

Dong-ki Lee, PhD
Global Research Laboratory for RNAi Medicine
Department of Chemistry
Sungkyunkwan University
Suwon, Korea
dklee@skku.edu; dklee0318@gmail.com

Editorial Board

Sidney Altman
Yale University
New Haven, CT

Serge L. Beaucage
Food & Drug Administration
Bethesda, MD

Mark A. Behlke
Integrated DNA Technologies
Coralville, IA

Ben Berkhout
University of Amsterdam Medical Center
Amsterdam, The Netherlands

Bob D. Brown
Dicerna Pharmaceuticals
Watertown, MA

Natasha Caplen
National Cancer Institute
Bethesda, MD

Marvin H. Caruthers
University of Colorado
Boulder, CO

David Corey
University of Texas Southwestern Medical Center
Dallas, TX

Mark E. Davis
California Institute of Technology
Pasadena, CA

Steven F. Dowdy
University of California San Diego 
La Jolla, CA  

Fritz Eckstein
Max-Planck Institute for Experimental Medicine
Göttingen, Germany

Michael Gait
Medical Research Council
Cambridge, United Kingdom

Krishna N. Ganesh
Indian Institute of Science Education and Research
Pune, India

Peter M. Glazer
Yale University
New Haven, CT

Martin Gleave
Vancouver General Hospital
Vancouver, Canada

Peixuan Guo
University of Kentucky
Lexington, KY  

Gunther Hartmann
Universitatsklinikum Bonn
Bonn, Germany

Richard I. Hogrefe
TriLink BioTechnologies, Inc
San Diego, CA

Leaf Huang
University of North Carolina 
Chapel Hill, NC

Kuan-Teh Jeang
NIAID/NIH
Bethesda, MD

Dong-Yan Jin
University of Hong Kong
Pokfulam, Hong Kong

Anthony D. Keefe
X-Chem Pharmaceuticals
Waltham, MA

Soyoun Kim
Dongguk University
Seoul, Korea

Troels Koch
Santaris Pharma A/S
Hørsholm, Denmark

Ryszard Kole
University of North Carolina 
Chapel Hill, NC

Arthur M. Krieg
RaNA Therapeutics, Inc.
Cambridge, MA

Bernard Lebleu
Universite Montpellier
Montpellier, France

Seong-Wook Lee
Dankook University
Yongin, Korea

Ian MacLachlan
Tekmira Pharmaceuticals 
Burnaby, Canada  

Claude Malvy
Institut Gustave Roussy
Villejuif, France

Paul S. Miller
Johns Hopkins University
Baltimore, MD

Brett P. Monia
Isis Pharmaceuticals, Inc.
Carlsbad, CA

Barbara Nawrot
Polish Academy of Sciences
Lodz, Poland

Georg Sczakie
University of Lübeck
Lübeck, Germany

Michael Seidman
National Institute on Aging
Baltimore, MD

Barbara Ramsay Shaw
Duke University
Durham, NC

Hermona Soreq
Hebrew University of Jerusalem 
Jerusalem, Israel

Wojciech Stec
Polish Academy of Sciences
Lodz, Poland

J.-J. Toulmé
Universite Victor Segalen 
Bordeaux, France

Thomas Tuschl
Rockefeller University
New York, NY

Takeshi Wada
University of Tokyo
Kashiwa, Japan

Jesper Wengel
University of Southern Denmark
Copenhagen, Denmark

Steve Wilton
University of Western Australia
Nedlands, Western Australia  

Yun Yen
City of Hope National Medical Center 
Duarte, CA